DeanKereiakesMD

Cardiology • Cincinnati, OH

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Clinical Professor of Medicine, Ohio State University

Join to view full profile

Dr. Kereiakes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kereiakes' full profile

Already have an account?

Office
2123 Auburn Avenue
Cincinnati, OH 45219
Phone+1 513-585-0215
Is this information wrong?

Summary

Dean J. Kereiakes, M.D., FACC, MSCAI is Chairman of The Christ Hospital Heart and Vascular Institute, Medical Director of the Christ Hospital Research Institute, and Professor of Clinical Medicine at The Ohio State University. Dr. Kereiakes has been an original investigator for most of the interventional technologies introduced in the last three decades and has performed more than 30,000 catheterization laboratory procedures. In addition to lecturing nationally and internationally, Dr. Kereiakes is active as a scientific investigator and has participated in over 1,600 clinical research protocols. He has published over 1,000 scientific journal articles, abstracts and book chapters. He has served on the editorial boards of Circulation, The Journal of the American College of Cardiology (JACC), Journal of the American College of Cardiology Cardiovascular Interventions, The American Heart Journal, The American Journal of Cardiology and is currently Deputy Editor for Journal of The Society for Cardiac Angiography and Intervention (JSCAI). He was previously Section Editor for Circulation and received the Simon Dack Award for Outstanding Scholarship from JACC in 2011. He was awarded an Honorary Doctorate of Sciences from University of Cincinnati in 2014 and was named an Outstanding Alumnus of U.C. College of Medicine.

Education & Training

University of California (San Francisco)Fellowship, Cardiovascular Disease, 1982 - 1984
Massachusetts General HospitalResidency, Internal Medicine, 1980 - 1981
University of California (San Francisco)Residency, Internal Medicine, 1978 - 1980
University of Cincinnati College of MedicineClass of 1978

Certifications & Licensure

CA State Medical License 1980 - 2026
OH State Medical License 1984 - 2024
IN State Medical License 1989 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
National Board of Physicians and Surgeons Cardiovascular Disease
National Board of Physicians and Surgeons Internal Medicine

Awards, Honors, & Recognition

Fellow Society of Cardiac Angiography & Intervention
America's Top Doctors Castle Connolly, 2002-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACC) American College of Cardiology
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II) Start of enrollment: 2005 May 01
Completed
Phase 3
MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients Start of enrollment: 2003 Oct 01
Completed
Not Applicable
MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients Start of enrollment: 2003 Oct 01
Completed
Not Applicable
The Effect of Betahistine on Body Weight in Obese Subjects Start of enrollment: 2007 Jan 01
Completed
Phase 2
TAXUS PERSEUS Workhorse Start of enrollment: 2007 Jul 01
Completed
Phase 3
TAXUS PERSEUS Small Vessel Start of enrollment: 2007 Jul 01
Completed
Phase 3
The Dual Antiplatelet Therapy Study (DAPT Study) Start of enrollment: 2009 Oct 01
Completed
Phase 4
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults Start of enrollment: 2010 Apr 01
Completed
Phase 3
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk Start of enrollment: 2011 Mar 01
Completed
Not Applicable
The OMEGA Clinical Trial Start of enrollment: 2011 Oct 01
Completed
Not Applicable
Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration Start of enrollment: 2012 Nov 13
Terminated
Phase 1, Phase 2
A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
Terminated
Phase 3
ABSORB III Randomized Controlled Trial (RCT) Start of enrollment: 2012 Dec 01
Completed
Not Applicable
Absorb IV Randomized Controlled Trial Start of enrollment: 2014 Jul 01
Completed
Not Applicable
PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis Start of enrollment: 2016 Mar 01
Active, not recruiting
Not Applicable
The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study Start of enrollment: 2016 Aug 01
Active, not recruiting
Not Applicable
Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. Start of enrollment: 2021 Dec 31
Not yet recruiting
Not Applicable
Personalized Therapy Study - Attain Stability Quad Post-Approval Study Start of enrollment: 2017 Aug 21
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.
Torsten P Vahl, Vinod H Thourani, Raj R Makkar, Nadira Hamid, Omar K Khalique, David Daniels, James M McCabe, Lowell Satler, Mark Russo, Wen Cheng, Isaac George, Gabri...> ;Lancet. 2024 Apr 13
Coronary intravascular lithotripsy for severe coronary artery calcification: The disrupt CAD I-IV trials.
Zachary M Visinoni, Daniel L Jurewitz, Dean J Kereiakes, Richard Shlofmitz, Evan Shlofmitz, Ziad Ali, Jonathan Hill, Michael S Lee> ;Cardiovascular Revascularization Medicine. 2024 Mar 3
Late Migration of a Transcatheter Heart Valve.
Alirhayim, Z., Kereiakes, D., Garcia, S.> ;JACC. Case Reports. 2024 Feb 21
1 citations
Management strategies and prognosis of patients ineligible for transcatheter mitral valve replacement.
Hasan, S., Morsi, M., Frakes, B., Bryson, M., Schmidt, C., Seshiah, P., Choo, J., Smith, J., Answini, G., Stewart-Dehner, T., Yasar, S., Jollis, J., Berlacher, M., Rat...> ;Cardiovascular Revascularization Medicine. 2024 Feb 10
Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor,...
Rikken, S., van 't Hof, A., Ten Berg, J., Coller, B., Kereiakes, D.> ;Journal of the American Heart Association. 2023 Dec 19
Technology viewpoint: Evolution in PCI: The next major advance in implant technology to restore vessel function.
Dean J Kereiakes, Shigeru Saito, Holger M Nef, Mark Webster, Stefan Verheye, Antonio Colombo> ;Cardiovascular Revascularization Medicine. 2024 Apr 1
Editorial: Intravascular lithotripsy for post-implant stent under-expansion.
Dean J Kereiakes> ;Cardiovascular Revascularization Medicine. 2024 Apr 1
1 citations
Impact of Calcium Eccentricity on the Safety and Effectiveness of Coronary Intravascular Lithotripsy: Pooled Analysis From the Disrupt CAD Studies.
Ziad A Ali, Dean J Kereiakes, Jonathan M Hill, Shigeru Saito, Carlo Di Mario, Benjamin Honton, Nieves Gonzalo, Robert F Riley, Akiko Maehara, Mitsuaki Matsumura, Doosu...> ;Circulation. Cardiovascular Interventions. 2023 Oct 1
Bleeding and Ischemic Risk Prediction in Patients With High Bleeding Risk (an EVOLVE Short DAPT Analysis).
Nino Mihatov, Ajay J Kirtane, Robert Stoler, Robert Feldman, Franz-Josef Neumann, Loukas Boutis, Naeem Tahirkheli, Dean J Kereiakes, Ralph Toelg, Islam Othman, Bernard...> ;The American Journal of Cardiology. 2023 Nov 15
Atheroablation Imaging Insights.
Dean J Kereiakes> ;JACC. Cardiovascular Interventions. 2023 Sep 11
1 citations
Effects of Elective Coronary Revascularization vs Medical Therapy Alone on Noncardiac Mortality: A Meta-Analysis.
Eliano P Navarese, Alexandra J Lansky, Michael E Farkouh, Klaudyna Grzelakowska, Marc P Bonaca, Diana A Gorog, Paolo Raggi, Malte Kelm, Brandon Yeo, Julia Umińska, Nic...> ;JACC. Cardiovascular Interventions. 2023 May 22
4 citations
5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique.
Gregg W Stone, Dean J Kereiakes, Tommaso Gori, D Christopher Metzger, Bernardo Stein, Matthew Erickson, Jan Torzewski, Ameer Kabour, Guy Piegari, Jeffrey Cavendish, Ba...> ;Journal of the American College of Cardiology. 2023 Jul 18
3 citations
Transcatheter Left Ventricular Restoration in Patients With Heart Failure.
Nadira Hamid, Ulrich P Jorde, Mark Reisman, Azeem Latib, D Scott Lim, Susan M Joseph, Alena Kurlianskaya, Oleg Polonetsky, Petr Neuzil, Vivek Reddy, Jason Foerst, Hema...> ;Journal of Cardiac Failure. 2023 Jul 1
Editorial: Super High-Pressure Balloons: Where Do They Fit in the Calcium Toolbox?
Dean J Kereiakes> ;Cardiovascular Revascularization Medicine. 2023 Sep 1
Bioadapting to Nature With a Novel Coronary Prosthesis.
Dean J Kereiakes> ;Cardiovascular Revascularization Medicine. 2023 Jan 1
QFR Facilitated Functional Lesion Assessment to Guide Revascularization: The Next Paradigm Shift?
Timothy D Henry, Dean J Kereiakes> ;JACC. Cardiovascular Interventions. 2022 Dec 26
SAPT After DAPT: Tailoring Platelet Inhibitor Therapy After PCI.
Dean J Kereiakes> ;JACC. Cardiovascular Interventions. 2022 Nov 28
3 citations
Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial.
David G Rizik, Vivek Rajagopal, Raj R Makkar, Tanvir Bajwa, Neal S Kleiman, Axel Linke, Dean J Kereiakes, Ron Waksman, Vinod H Thourani, Robert C Stoler, Gregory J Mis...> ;JAMA Network Open. 2022 Oct 3
Intravascular Lithotripsy for Treatment of Calcified Coronary Artery Disease.
Dean J Kereiakes, Ziad A Ali, Robert F Riley, Timothy D Smith, Richard A Shlofmitz> ;Interventional Cardiology Clinics. 2022 Oct 1
Between a Rock and a Hard Place: Calcium Modification for Vascular Intervention.
Dean J Kereiakes> ;JACC. Cardiovascular Interventions. 2022 Sep 26
1 citations
Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study.
Nino Mihatov, Eric A Secemsky, Dean J Kereiakes, P Gabriel Steg, Donald E Cutlip, Ajay J Kirtane, Roxana Mehran, Bokai Zhao, Yang Song, C Michael Gibson, Robert W Yeh> ;Cardiovascular Revascularization Medicine. 2022 Aug 1
Clinical and angiographic success and safety comparison of coronary intravascular lithotripsy: An updated meta-analysis.
Yasar Sattar, Talal Almas, Junaid Arshad, Mohamed Zghouzi, Waqas Ullah, Tanveer Mir, Mohamed O Mohamed, Islam Y Elgendy, Wael Aljaroudi, Anand Prasad, Richard Shlofmit...> ;International Journal of Cardiology. Heart & Vasculature. 2022 Apr 1
Differential Clinical Benefit With Contemporary Drug-Eluting Stents: Fact or Fancy?
Dean J Kereiakes> ;JACC. Asia. 2022 Apr 1
1 citations
DES and DAPT in Evolution: Will Clinical Guidelines Follow?
Dean J Kereiakes, Robert W Yeh> ;JACC. Cardiovascular Interventions. 2022 Feb 14
9 citations
Preliminary Evaluation of a Novel Polymeric Valve Following Surgical Implantation for Symptomatic Aortic Valve Disease.
Dean J Kereiakes, Geoff A Answini, Steven J Yakubov, Balaj Rai, J Michael Smith, Steven Duff, Francis L Shannon, Marc Sakwa, Jason Beith, David Heimansohn> ;JACC. Cardiovascular Interventions. 2021 Dec 27
Join now to see all

Journal Articles

Drug-Coated Balloons for in-Stent Restenosis
Dean Kereiakes, MD, JACC: Cardiovascular Imaging

Lectures

Overview of Expanding Applications
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
Final 5-Year Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated Everolimus-Eluting SYNERGY Stent
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Interventional Live Case Session IV: Coronary Transmission from University of Washington Medical Center
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

Bioresorbable Vascular Scaffolds: Why and How?October 2019
Bioresorbable Vascular Scaffolds: Why and How?October 2019
New Insights into Bioresorbable Vascular Scaffolds Gained from Longer-Term Follow-UpOctober 2018
New Insights into Bioresorbable Vascular Scaffolds Gained from Longer-Term Follow-UpOctober 2018
Join now to see all

Press Mentions

Ancora Heart Inc. And Egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure PatientsApril 20th, 2023
Christ Hospital Health Network Launches Region's Second Adult Heart Transplant ProgramOctober 6th, 2022
Cardiovascular Devices Lead FDA Breakthrough Device Designation ProgramAugust 4th, 2022
Join now to see all